Geopolitical uncertainties, pricing pressure in core portfolio in the U.S., higher R&D expenses likely to drag revenue up to 20%, profit 30% in current fiscal
Business
Natco Pharma logs highest-ever sales, net in FY25, wary of headwinds for U.S. business in FY26
by aweeincm1
Recent Post
Rajasthan Man Who Spent 90 Days In Pak And Sent SIM Cards Arrested: Cops
The Delhi Police has arrested a man from Rajasthan for ... Read more
“Talks, Terror Cannot Go Together”: India On Pakistan PM’s “Peace” Call
External Affairs Ministry Spokesperson Randhir Jaiswal on Thursday said the ... Read more
“Every Student Can Find Their Harvard”: FAQs On Studying Abroad Answered
With rising competition and evolving global policies, expert guidance has ... Read more
How Indians Stand As Donald Trump’s Team Orders Pause On US Student Visas
India has for years been among the top two countries ... Read more